![Latest Company News - Finance News Network artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts114/v4/3d/68/c7/3d68c7fe-03ed-db1f-da4f-f89a9ad20cef/mza_14471249752386214790.png/100x100bb.jpg)
AFT Pharmaceuticals (ASX:AFP) signs Europe deal for Pascomer drug
Latest Company News - Finance News Network
English - March 17, 2021 00:00 - 56 seconds - 1000 KBBusiness News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: CEO Louis DiNardo set to leave BrainChip Holdings Ltd (ASX:BRN)
17 Mar 2021 - AFT Pharmaceuticals (ASX:AFP) has signed a new commercialisation and development agreement for its orphan drug Pascomer.